ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
27 hedge funds and large institutions have $30.9M invested in Elevation Oncology in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
Holders
27
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$1.75M | |
| 2 | +$982K | |
| 3 | +$825K | |
| 4 |
Morgan Stanley
New York
|
+$282K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$233K |
Top Sellers
| 1 | -$282K | |
| 2 | -$274K | |
| 3 | -$148K | |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$38K |
| 5 |
BlackRock
New York
|
-$9.1K |